(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 14.82% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.99%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Inspire Medical Systems's revenue in 2025 is $840,111,000.On average, 8 Wall Street analysts forecast INSP's revenue for 2025 to be $27,993,863,025, with the lowest INSP revenue forecast at $27,915,999,066, and the highest INSP revenue forecast at $28,039,401,644. On average, 8 Wall Street analysts forecast INSP's revenue for 2026 to be $32,530,058,030, with the lowest INSP revenue forecast at $32,107,085,666, and the highest INSP revenue forecast at $33,162,378,267.
In 2027, INSP is forecast to generate $37,625,251,377 in revenue, with the lowest revenue forecast at $36,398,451,608 and the highest revenue forecast at $38,654,736,794.